If your child’s glasses prescription keeps getting stronger, you may be wondering whether anything can be done to slow those changes. It’s a question I regularly discuss with parents, particularly when their children become short-sighted at a young age.
One treatment you may have heard about is Eikance, a prescription eye drop containing low-dose atropine. In Australia, it is registered for use in managing childhood myopia progression, with three different concentrations now available.
My name is David Truong, and I’m the Owner and Principal Optometrist at Beyond Eyecare in Sydney. I’ll explain what Eikance is, what the clinical research tells us, and what parents should understand about its use, side effects and ongoing monitoring.
KEY TAKEAWAYS
- Eikance contains low-dose atropine, which is used to slow the progression of childhood short-sightedness. It doesn’t reverse existing myopia.
- Three concentrations are registered in Australia: 0.01%, 0.025% and 0.05%. The appropriate strength depends on the child’s clinical circumstances.
- Research suggests that stronger low-dose atropine concentrations generally provide greater myopia control, although side effects can become more noticeable.
- Eikance is a prescription treatment requiring professional supervision, consistent administration and regular reviews to assess its effectiveness.
What Is Eikance And How Does It Help Control Myopia?
Eikance is a prescription eye drop containing atropine sulfate, a medicine that has been investigated extensively for managing childhood myopia.
Myopia, or short-sightedness, commonly develops when the eyeball becomes excessively elongated from front to back. This causes light to focus in front of the retina, making distant objects appear blurry.
Some eye growth is perfectly normal during childhood. The concern is about excessive axial elongation as the eyes develop.
Low-dose atropine can help reduce the rate of prescription change and axial elongation in some children. Researchers are still investigating exactly how it produces these effects.
Importantly, Eikance doesn’t correct existing short-sightedness. Children receiving treatment will generally continue wearing their prescribed glasses or contact lenses.
Why was Eikance introduced in Australia?
Before commercially manufactured low-dose atropine became available, prescriptions for childhood myopia management generally relied on specially prepared drops from compounding pharmacies.
Eikance 0.01% was added to the Australian Register of Therapeutic Goods in September 2021, providing a commercially manufactured alternative.
Two additional strengths were registered in February 2026, expanding the concentrations available for clinicians to consider.

What Is The Difference Between Eikance 0.01%, 0.025% And 0.05%?
The three registered strengths contain the same active ingredient, atropine sulfate, but at different concentrations.
| Eikance concentration | Clinical considerations |
|---|---|
| 0.01% | Lowest concentration, generally associated with fewer effects on pupil size and near focusing, although effectiveness varies |
| 0.025% | Intermediate concentration, offering another option when balancing myopia progression and tolerability |
| 0.05% | Highest registered concentration, associated with stronger myopia-control effects in clinical research, but potentially more noticeable side effects |
All three concentrations are registered for treatment initiated in children aged four to fourteen.
According to the Australian product information, treatment may be an option when myopia progresses by at least 0.50 dioptres per year or axial length increases by 0.20 mm annually.
These figures provide guidance rather than replacing an individual clinical assessment.
Does a stronger concentration always work better?
Not necessarily for every child.
Higher concentrations have generally produced stronger treatment effects in some major clinical studies. However, increasing the concentration can also produce more noticeable pupil dilation, light sensitivity and near-focusing difficulties.
A child’s age, previous progression, eye measurements and tolerance all influence treatment decisions.
The objective is to select an appropriate concentration and monitor the response, rather than automatically choosing the strongest option.
How Effective Is Low-Dose Atropine For Childhood Myopia?
One of the most informative research programmes is the Low-Concentration Atropine for Myopia Progression (LAMP) study, conducted in Hong Kong.
The randomised clinical trial published in Ophthalmology compared three atropine concentrations with a placebo in children with myopia.
The average results after 12 months were:
| Treatment group | Average prescription change | Average axial elongation |
|---|---|---|
| Atropine 0.05% | −0.27 D | 0.20 mm |
| Atropine 0.025% | −0.46 D | 0.29 mm |
| Atropine 0.01% | −0.59 D | 0.36 mm |
| Placebo | −0.81 D | 0.41 mm |
The 0.05% concentration produced the smallest average prescription change and axial elongation in this study.
The researchers also reported that all three concentrations were generally well tolerated.
These findings help explain why clinicians consider different atropine strengths when managing childhood myopia.
However, the research investigated low-dose atropine formulations, rather than the Eikance-branded product specifically.
Results also vary between studies and populations. For example, a 2023 American randomised trial found that atropine 0.01% did not significantly slow myopia progression compared with placebo.
That doesn’t negate the findings of the LAMP study, but it demonstrates why treatment decisions need to consider the available evidence and individual circumstances.
What Side Effects Can Eikance Eye Drops Cause?
Low-dose atropine is generally tolerated by children, but it can cause side effects. Some become more noticeable at higher concentrations.
The main ones parents should understand are:
- Sensitivity to bright light: Atropine can enlarge the pupils, making sunlight uncomfortable. Sunglasses or photochromic lenses may help.
- Difficulty focusing up close: Some children notice blurred vision when reading or completing schoolwork.
- Eye irritation: Temporary stinging, redness or discomfort may occur after administration.
- Other reactions: Headaches, fatigue or allergic symptoms are also possible.
If your child experiences troublesome light sensitivity, reading difficulties or persistent irritation, contact their treating clinician.
More significant symptoms, including marked swelling, an allergic reaction or unexpected changes in vision, require prompt medical assessment.
It’s also important to tell the prescribing clinician about other medications, allergies, glaucoma or a family history of glaucoma before treatment begins.
Parents can consult the official Eikance Consumer Medicine Information for the full list of precautions and possible side effects.
How Do Parents Give Their Child Eikance Eye Drops?
Eikance is normally administered once each evening, according to the prescribing clinician’s instructions.
The drops come in preservative-free, single-use containers.
The basic application process is straightforward:
- Wash your hands and open a single-use container.
- Ask your child to look upwards and gently pull down their lower eyelid.
- Place the prescribed drop into the space between the lower eyelid and the eye, without touching the eye with the container tip.
- Ask your child to close their eyes gently. Apply light pressure near the inner corner for approximately one minute to reduce drainage into the nose.
- Repeat for the other eye if prescribed, then discard the container, even if some solution remains.
Younger children will generally need help until they’re comfortable with the routine.
If your child wears contact lenses, remove them before administering the drops and wait at least 15 minutes before reinserting them.
Store Eikance below 25°C, protected from light, following the packaging instructions.
What happens if we forget a dose?
Follow the instructions in the Consumer Medicine Information or ask your pharmacist.
Generally, a missed dose can be given when remembered, unless it’s nearly time for the next scheduled dose. Don’t double the dose to compensate.
Consistency matters because atropine is a longer-term treatment rather than something used occasionally when a child’s vision seems worse.
How Do We Decide Whether Eikance Is Appropriate For A Child?
At Beyond Eyecare, assessing childhood myopia involves looking at how the child’s prescription has changed and whether their eyes are showing excessive axial elongation.
Two measurements are particularly useful:
- Prescription change, measured in dioptres, shows how the focusing correction is changing.
- Axial elongation, measured in millimetres, shows how much the eye has lengthened from front to back.
We also consider age, family history, current visual needs and how practical a daily treatment routine would be.
When a child uses atropine eye drops, regular reviews help their treating clinician monitor myopia progression, check for side effects and decide whether to adjust treatment.
We may also consider other myopia-management options, including specialised spectacle lenses, soft contact lenses or Ortho-K. In some cases, combining treatments may be a better approach.
Parents should never independently increase the atropine concentration or discontinue treatment without discussing the decision with the prescribing clinician.
Final Thoughts
If your child’s short-sightedness is getting progressively worse, don’t assume that updating their glasses prescription is the only action worth taking.
Childhood myopia deserves ongoing attention because the changes occurring during these years can influence eye health later in life.
Eikance offers one option for managing childhood myopia, but first we need to establish how quickly your child’s short-sightedness is progressing.
I’d encourage Sydney parents to arrange a comprehensive eye examination if their child’s prescription has been increasing. At Beyond Eyecare, we can assess their vision, review the available management options and discuss an appropriate monitoring plan.
The earlier we understand the pattern of progression, the better informed our decisions about managing it can be.
Book an appointment with Beyond Eyecare today at Zetland (02) 9662 6364 or Surry Hills (02) 9556 1160. You can also schedule a convenient time through our website.

Therapeutical endorsement





